Asymptomatic Hyperamylasemia in Stevens‐Johnson Syndrome Is Associated with Intestinal Barrier Dysfunction
Authors:
Open Access
- 1 January 2020
- journal article
- research article
- Published by Wiley in BioMed Research International
- Vol. 2020 (1)
Abstract
Background/Objectives. Stevens‐Johnson syndrome (SJS) is an allergic disease characterized by extensive epidermal detachment and mucositis. SJS involves both the skin and mucosal membranes, including the gastrointestinal tract. The present study is aimed at understanding the underlying reason of asymptomatic hyperamylasemia in patients with SJS, which may be associated with mucosal injury of the GI tract. Methods. A retrospective study on SJS patients was conducted at a tertiary medical center. All patients diagnosed as SJS, with available serum amylase index, were included. Clinical data of all subjects were retrospectively collected and analyzed. Colonic mucosal biopsies were obtained to measure tight junction protein expression. Results. A total of nine patients were included in the present study for study analysis. The average serum amylase of the study cohort was 228.78 ± 204.18 U/L. Among which, five patients had a positive fecal occult blood test (FOBT). Colonic mucosal biopsies were obtained and stained with occludin and zonula occludens‐1 (ZO‐1). The expression of occludin and ZO‐1 was significantly downregulated in SJS patients (p < 0.01), which was indicative of intestinal barrier dysfunction. Conclusion. Hyperamylasemia often extends beyond pancreatic diseases. Clinical awareness of asymptomatic hyperamylasemia secondary to other systemic diseases can help avoid unnecessary overexamination and overtreatment.Keywords
Funding Information
- National Natural Science Foundation of China (81870456, 81500503)
This publication has 21 references indexed in Scilit:
- UK guidelines for the management of Stevens–Johnson syndrome/toxic epidermal necrolysis in adults 2016Journal of Plastic, Reconstructive & Aesthetic Surgery, 2016
- PANCREATITIS OR NOT? – Elevated lipase and amylase in ICU patientsJournal of Critical Care, 2015
- Stevens–Johnson Syndrome and Toxic Epidermal Necrolysis: An UpdateAmerican Journal of Clinical Dermatology, 2015
- Hyperamylasemia is associated with increased intestinal permeability in patients undergoing diagnostic oral double-balloon enteroscopyWorld Journal of Gastroenterology, 2014
- Tight junction proteins: From barrier to tumorigenesisCancer Letters, 2013
- Systematic review of treatments for Stevens–Johnson syndrome and toxic epidermal necrolysis using the SCORTEN score as a tool for evaluating mortalityTherapeutic Advances in Drug Safety, 2011
- Asymptomatic Hyperamylasemia and Hyperlipasemia in Pediatric Patients With Toxic Epidermal NecrolysisJournal of Burn Care & Research, 2010
- Pancreatic hyperenzymemia: clinical significance and diagnostic approach.2005
- Gastroenteritis-Associated HyperamylasemiaArchives of internal medicine (1960), 2002
- AMYLASE—ITS CLINICAL SIGNIFICANCE: A REVIEW OF THE LITERATUREMedicine, 1976